In 2023, Germany's share of scientific publications among the world's top 10% cited in pharmacy stood at 6.98%. Forecasts from 2024 to 2028 indicate a slight downward trend, with values decreasing from 6.87% in 2024 to 6.46% by 2028. The year-on-year decrease suggests a gradual reduction in Germany's relative positioning in high-impact pharmacy research outputs.

Future trends to watch for include:

Germany's strategic focus on boosting research quality to counterbalance the predicted decline.
Potential investments in interdisciplinary approaches to improve publication impact.
Global collaboration and funding shifts that may influence Germany's standing in the sector.